UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum

Nature communications, 2018-03, Vol.9 (1), p.1178-9, Article 1178

2018

Volltextzugriff (PDF)

Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab

PloS one, 2013-02, Vol.8 (2), p.e56112-e56112

2013

Volltextzugriff (PDF)

Pregnant, miserable, and starving in 21st century America

AJOG global reports, 2023-02, Vol.3 (1), p.100141-100141, Article 100141

2023

Volltextzugriff (PDF)

ADRM1-amplified metastasis gene in gastric cancer

Genes chromosomes & cancer, 2015-08, Vol.54 (8), p.506-515

2015

Volltextzugriff (PDF)

Hyperemesis gravidarum: it is time to put an end to the misguided theory of a psychiatric etiology

General hospital psychiatry, 2012-11, Vol.34 (6), p.699-700

2012

Volltextzugriff (PDF)

Familial aggregation of hyperemesis gravidarum

American journal of obstetrics and gynecology, 2011-03, Vol.204 (3), p.230.e1-230.e7

2011

Volltextzugriff (PDF)

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer

International journal of molecular sciences, 2013-02, Vol.14 (2), p.3094-3109

2013

Volltextzugriff (PDF)

High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals

European journal of obstetrics & gynecology and reproductive biology, 2008-11, Vol.141 (1), p.13-17

2008

Volltextzugriff (PDF)

Whole‐exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum

BJOG : an international journal of obstetrics and gynaecology, 2022-10, Vol.129 (11), p.1845-1852

2022

Volltextzugriff (PDF)

Psychiatric factors do not affect recurrence risk of hyperemesis gravidarum

The journal of obstetrics and gynaecology research, 2015-04, Vol.41 (4), p.512-516

2015

Volltextzugriff (PDF)

Inaccuracies in “Long-term health outcomes of children born to mothers with hyperemesis gravidarum: a systematic review and meta-analysis”

American journal of obstetrics and gynecology, 2022-11, Vol.227 (5), p.792-792

2022

Volltextzugriff (PDF)

Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target

Genes chromosomes & cancer, 2008-10, Vol.47 (10), p.873-883

2008

Volltextzugriff (PDF)

Nausea and vomiting of pregnancy and hyperemesis gravidarum

Nature reviews. Disease primers, 2019-09, Vol.5 (1), p.62-62, Article 62

2019

Volltextzugriff (PDF)

Nausea and Vomiting of Pregnancy and HG Risk Genes Associated With Blood Levels, Sleep, Stomach Pain, and Other Traits [23N]

Obstetrics and gynecology (New York. 1953), 2020-05, Vol.135 (1), p.151-152S

2020

Volltextzugriff (PDF)

Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition

Gynecologic oncology, 2021-02, Vol.160 (2), p.539-546

2021

Volltextzugriff (PDF)

Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States

Reproductive toxicology (Elmsford, N.Y.), 2016-07, Vol.62, p.87-91

2016

Volltextzugriff (PDF)

Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK

Genes chromosomes & cancer, 2011-06, Vol.50 (6), p.434-441

2011

Volltextzugriff (PDF)

Neurodevelopmental delay in children exposed in utero to hyperemesis gravidarum

European journal of obstetrics & gynecology and reproductive biology, 2015-06, Vol.189, p.79-84

2015

Volltextzugriff (PDF)

Patients with a history of hyperemesis gravidarum have similar symptoms during egg stimulation and develop ovarian hyperstimulation syndrome: case series

Fertility and sterility, 2010-01, Vol.93 (1), p.267.e9-267.e11

2010

Volltextzugriff (PDF)

Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo

Clinical cancer research, 2010-03, Vol.16 (5), p.1509-1519

2010

Volltextzugriff (PDF)

HyperEmesis Level Prediction (HELP Score) Identifies Patients with Indicators of Severe Disease: a Validation Study

Geburtshilfe und Frauenheilkunde, 2021-01, Vol.81 (1), p.90-98

2021

Volltextzugriff (PDF)

Proteasome ubiquitin receptor PSMD4 is an amplification target in breast cancer and may predict sensitivity to PARPi

Genes chromosomes & cancer, 2017-08, Vol.56 (8), p.589-597

2017

Volltextzugriff (PDF)

Intestinal obstruction is a rare complication of ondansetron exposure in hyperemesis gravidarum

Reproductive toxicology (Elmsford, N.Y.), 2015-11, Vol.57, p.207-207

2015

Volltextzugriff (PDF)

Evidence GDF15 Plays a Role in Familial and Recurrent Hyperemesis Gravidarum

Geburtshilfe und Frauenheilkunde, 2018-09, Vol.78 (9), p.866-870

2018

Volltextzugriff (PDF)

Periostin promotes ovarian cancer angiogenesis and metastasis

Gynecologic oncology, 2010-11, Vol.119 (2), p.337-344

2010

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(78)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum

Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab

Pregnant, miserable, and starving in 21st century America

ADRM1-amplified metastasis gene in gastric cancer

Hyperemesis gravidarum: it is time to put an end to the misguided theory of a psychiatric etiology

Familial aggregation of hyperemesis gravidarum

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer

High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals

Whole‐exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum

Psychiatric factors do not affect recurrence risk of hyperemesis gravidarum

Inaccuracies in “Long-term health outcomes of children born to mothers with hyperemesis gravidarum: a systematic review and meta-analysis”

Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target

Nausea and vomiting of pregnancy and hyperemesis gravidarum

Nausea and Vomiting of Pregnancy and HG Risk Genes Associated With Blood Levels, Sleep, Stomach Pain, and Other Traits [23N]

Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition

Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States

Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK

Neurodevelopmental delay in children exposed in utero to hyperemesis gravidarum

Patients with a history of hyperemesis gravidarum have similar symptoms during egg stimulation and develop ovarian hyperstimulation syndrome: case series

Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo

HyperEmesis Level Prediction (HELP Score) Identifies Patients with Indicators of Severe Disease: a Validation Study

Proteasome ubiquitin receptor PSMD4 is an amplification target in breast cancer and may predict sensitivity to PARPi

Intestinal obstruction is a rare complication of ondansetron exposure in hyperemesis gravidarum

Evidence GDF15 Plays a Role in Familial and Recurrent Hyperemesis Gravidarum

Periostin promotes ovarian cancer angiogenesis and metastasis

Suchergebnisse filtern